Pay in 4 interest-free payments of $6.44 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
A smaller body requires fewer calories to maintain
The primary advantage is superior bioavailability
This leads to a decrease in appetite and food intake, which can help people to lose weight
As a triple incretin receptor agonist, it: Activates GLP-1 receptors , reducing appetite, slowing gastric emptying, and improving insulin secretion Activates GIP receptors , enhancing insulin response and potentially supporting fat metabolism Activates glucagon receptors , increasing energy expenditure and hepatic glucose output Whilst glucagon receptor activation increases hepatic glucose output, the net glycaemic effect of retatrutide is mitigated by the concurrent GLP-1 and GIP activity, resulting in overall improvements in glycaemic control in trial participants
About a decade ago, adult obesity rates of 35% were unheard of in the U.S
US$ 22.43
US$ 22.43
US$ 20.28
US$ 24.13
US$ 24.34
